US Stem Cell Inc (OTCMKTS:USRM) HEFFX Highlights
- US Stem Cell Inc (USRM) Seeing Increased Volatility in Session
- Shareholder Confidence Builds on US Stem Cell
- Scientists Coax Stem Cells Into Functional Red Blood Cells
- California’s $3-billion bet on stem cells faces final test
- US Stem Cell Inc (OTCMKTS:USRM) announced that it had received a commitment to invest up to $5,000,000 from private equity firm General American Capital Partners LLC (GACP) in exchange for up to 63,873,275 shares of common stock.
U.S. Stem Cell, Inc., formerly Bioheart, Inc., is a biotechnology company. The Company is focused on the discovery, development and, subject to regulatory approval, commercialization of autologous cell therapies for the treatment of chronic and acute heart damage. Its MyoCell is a clinical therapy designed to populate regions of scar tissue within a patient’s heart with autologous muscle cells, or cells from a patient’s body, for the purpose of improving cardiac function in chronic heart failure patients. Its AdipoCell is a cell therapy with multiple possible treatment applications using autologous adipose cells. Its business includes the development of cell therapy products, as well as physician and patient-based regenerative medicine/cell therapy training services, and the sale of cell collection and treatment kits for humans and animals, and the operation of a cell therapy clinic. It operates through divisions, including US Stem Cell Training, Vetbiologics and US Stem Cell Clinic.
Overall, the bias in prices is: Upwards.
Short term: Prices are moving.
Intermediate term: Prices are trending.
Note: this chart shows extraordinary price action to the upside.
The projected upper bound is: 0.16.
The projected lower bound is: 0.09.
The projected closing price is: 0.12.
U S STEM CELL closed up 0.018 at 0.123. Volume was 48% below average (neutral) and Bollinger Bands were 11% narrower than normal.
Open High Low Close Volume
0.107 0.130 0.107 0.123 11,054,231
Short Term: Neutral
Intermediate Term: Bearish
Long Term: Bullish
Moving Averages: 10-period 50-period 200-period
Close: 0.10 0.09 0.03
Volatility: 148 304 409
Volume: 5,141,926 18,776,992 10,868,120
Short-term traders should pay closer attention to buy/sell arrows while intermediate/long-term traders should place greater emphasis on the Bullish or Bearish trend reflected in the lower ribbon.
U S STEM CELL is currently 339.5% above its 200-period moving average and is in an downward trend. Volatility is relatively normal as compared to the average volatility over the last 10 periods. Our volume indicators reflect moderate flows of volume into USRM.PK (mildly bullish). Our trend forecasting oscillators are currently bearish on USRM.PK and have had this outlook for the last 22 periods.
Momentum is a general term used to describe the speed at which prices move over a given time period. Generally, changes in momentum tend to lead to changes in prices. This expert shows the current values of four popular momentum indicators.
One method of interpreting the Stochastic Oscillator is looking for overbought areas (above 80) and oversold areas (below 20). The Stochastic Oscillator is 56.7031. This is not an overbought or oversold reading. The last signal was a buy 26 period(s) ago.
Relative Strength Index (RSI)
The RSI shows overbought (above 70) and oversold (below 30) areas. The current value of the RSI is 64.84. This is not a topping or bottoming area. A buy or sell signal is generated when the RSI moves out of an overbought/oversold area. The last signal was a sell 36 period(s) ago.
Commodity Channel Index (CCI)
The CCI shows overbought (above 100) and oversold (below -100) areas. The current value of the CCI is 269.This is an overbought reading. However, a signal isn’t generated until the indicator crosses below 100. The last signal was a sell 2 period(s) ago.
The Moving Average Convergence/Divergence indicator (MACD) gives signals when it crosses its 9 period signal line. The last signal was a buy 13 period(s) ago.